EMMA Director makes notable purchase.Bullish volume and a insider purchase by director Zen Wei Peu may ass some more furl to the rally in EMMA. We will await for a much higher bounce before considering a long.
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company. It engages in the discovery, development, marketing
Emmaus Life Sciences, Inc.
0.0137USDD
−0.0004−3.01%
At close at Jul 16, 17:45 GMT
USD
No trades
Next report date
≈
August 18
Report period
Q2 2025
EPS estimate
—
Revenue estimate
—
−0.0697 USD
−6.45 M USD
16.65 M USD
35.58 M
About Emmaus Life Sciences, Inc.
Sector
Industry
CEO
Willis C. Lee
Website
Headquarters
Torrance
Founded
1987
FIGI
BBG000BQC327
Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
−180%
−120%
−60%
0%
60%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−6.00 M
−3.00 M
0.00
3.00 M
6.00 M
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−2.60 M
−1.30 M
0.00
1.30 M
2.60 M
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−2.60 M
−1.30 M
0.00
1.30 M
2.60 M
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−12.00 M
0.00
12.00 M
24.00 M
36.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EMMA is 0.0137 USD — it has decreased by −3.01% in the past 24 hours. Watch Emmaus Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Emmaus Life Sciences, Inc. stocks are traded under the ticker EMMA.
EMMA stock has fallen by −2.49% compared to the previous week, the month change is a −15.69% fall, over the last year Emmaus Life Sciences, Inc. has showed a −80.79% decrease.
EMMA reached its all-time high on Jan 3, 2008 with the price of 30,593.8800 USD, and its all-time low was 0.0001 USD and was reached on Aug 14, 2024. View more price dynamics on EMMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EMMA stock is 3.10% volatile and has beta coefficient of 79.63. Track Emmaus Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Emmaus Life Sciences, Inc. there?
Yes, you can track Emmaus Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Emmaus Life Sciences, Inc. is going to release the next earnings report on Aug 18, 2025. Keep track of upcoming events with our Earnings Calendar.
EMMA net income for the last quarter is −2.33 M USD, while the quarter before that showed −1.75 M USD of net income which accounts for −33.30% change. Track more Emmaus Life Sciences, Inc. financial stats to get the full picture.
No, EMMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 19, 2025, the company has 35 employees. See our rating of the largest employees — is Emmaus Life Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Emmaus Life Sciences, Inc. EBITDA is −113.00 K USD, and current EBITDA margin is −11.24%. See more stats in Emmaus Life Sciences, Inc. financial statements.
Like other stocks, EMMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Emmaus Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Emmaus Life Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Emmaus Life Sciences, Inc. stock shows the sell signal. See more of Emmaus Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.